239 related articles for article (PubMed ID: 31134061)
1. Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.
Csete D; Simon E; Alatshan A; Aradi P; Dobó-Nagy C; Jakus Z; Benkő S; Győri DS; Mócsai A
Front Immunol; 2019; 10():937. PubMed ID: 31134061
[TBL] [Abstract][Full Text] [Related]
2. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
3. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
4. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption.
Zou W; Kitaura H; Reeve J; Long F; Tybulewicz VL; Shattil SJ; Ginsberg MH; Ross FP; Teitelbaum SL
J Cell Biol; 2007 Mar; 176(6):877-88. PubMed ID: 17353363
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.
Mócsai A; Humphrey MB; Van Ziffle JA; Hu Y; Burghardt A; Spusta SC; Majumdar S; Lanier LL; Lowell CA; Nakamura MC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6158-63. PubMed ID: 15073337
[TBL] [Abstract][Full Text] [Related]
6. Runx1-mediated regulation of osteoclast differentiation and function.
Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo.
Yu TY; Kondo T; Matsumoto T; Fujii-Kuriyama Y; Imai Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):416-22. PubMed ID: 24938130
[TBL] [Abstract][Full Text] [Related]
8. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3.
Zhang Y; Zhang S; Wang Y; Yang Z; Chen Z; Wen N; Yang M; Huang Z; Xie Y; Cai L
Oxid Med Cell Longev; 2021; 2021():2896674. PubMed ID: 34820053
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
10. Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase.
Jia Y; Miao Y; Yue M; Shu M; Wei Z; Dai Y
FASEB J; 2018 Jun; 32(6):3398-3410. PubMed ID: 29401630
[TBL] [Abstract][Full Text] [Related]
11. Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.
Kittaka M; Yoshimoto T; Schlosser C; Rottapel R; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2020 Feb; 35(2):382-395. PubMed ID: 31613396
[TBL] [Abstract][Full Text] [Related]
12. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice.
Sui X; Deng S; Liu M; Fan L; Wang Y; Xu H; Sun Y; Kishen A; Zhang Q
Cell Physiol Biochem; 2018; 48(5):2091-2102. PubMed ID: 30107384
[TBL] [Abstract][Full Text] [Related]
14. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss.
Wu Y; Tworkoski K; Michaud M; Madri JA
J Immunol; 2009 Mar; 182(5):2672-9. PubMed ID: 19234161
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptors in osteoclast lineage cells are a negative regulator of bone mass.
Yu TY; Pang WJ; Yang GS
PLoS One; 2015; 10(1):e0117112. PubMed ID: 25615839
[TBL] [Abstract][Full Text] [Related]
17. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
[TBL] [Abstract][Full Text] [Related]
18. Increased bone resorption by osteoclast-specific deletion of the sodium/calcium exchanger isoform 1 (NCX1).
Albano G; Dolder S; Siegrist M; Mercier-Zuber A; Auberson M; Stoudmann C; Hofstetter W; Bonny O; Fuster DG
Pflugers Arch; 2017 Feb; 469(2):225-233. PubMed ID: 27942992
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Wnt5a in osteoclasts results in bone loss through decreased bone formation.
Roberts JL; Liu G; Paglia DN; Kinter CW; Fernandes LM; Lorenzo J; Hansen MF; Arif A; Drissi H
Ann N Y Acad Sci; 2020 Mar; 1463(1):45-59. PubMed ID: 31919867
[TBL] [Abstract][Full Text] [Related]
20. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
